ReviewJournal of neuromuscular diseases2026

Changes in RNA splicing as a surrogate endpoint for myotonic dystrophy Type 1 (DM1) clinical trials.

J Andrew Berglund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.